4/A//SEC Filing
VON RICKENBACH JOSEF H 4/A
Accession 0000950170-24-043362
CIK 0001420565other
Filed
Apr 9, 8:00 PM ET
Accepted
Apr 10, 4:15 PM ET
Size
5.7 KB
Accession
0000950170-24-043362
Insider Transaction Report
Form 4/AAmended
VON RICKENBACH JOSEF H
Director
Transactions
- Award
Stock Option (right to buy)
2024-02-28+2,725→ 2,725 totalExercise: $4.72Exp: 2034-02-27→ Common Stock (2,725 underlying)
Footnotes (1)
- [F1]This option was granted on February 28, 2024. The shares underlying the option are scheduled to vest in full on the earlier of (i) February 28, 2025 or (ii) the date of the Issuer's 2024 Annual Meeting of Stockholders.
Documents
Issuer
Aileron Therapeutics, Inc.
CIK 0001420565
Entity typeother
Related Parties
1- filerCIK 0001007706
Filing Metadata
- Form type
- 4/A
- Filed
- Apr 9, 8:00 PM ET
- Accepted
- Apr 10, 4:15 PM ET
- Size
- 5.7 KB